VALENTINA SIMON
Yale researchers discover that novel antiviral effectively targets numerous COVID variants
A Yale study found that an RNA-based antiviral recruits the innate immune system in the body’s fight against COVID-19, indiscriminately fighting many variants of the virus and bringing new hope to immunocompromised patients.
November 15, 2021